Wellcome Trust-funded stem cell research has produced red blood cells fit for transfusion into humans, paving the way for the mass production of blood
It is the stuff of gothic science fiction: men in white coats in factories of blood and bones.
But the production of blood on an industrial scale could become a reality once a trial is conducted in which artificial blood made from human stem cells is tested in patients for the first time.
It is the latest breakthrough in scientists’ efforts to re-engineer the body, which have already resulted in the likes of 3d-printed bones and bionic limbs.
Marc Turner, the principal researcher in the £5 million programme funded by the Wellcome Trust, told The Telegraph that his team had made red blood cells fit for clinical transfusion.
Prof Turner has devised a technique to culture red blood cells from induced pluripotent stem (iPS) cells – cells that have been taken from humans and ‘rewound’ into stem cells. Biochemical conditions similar to those in the human body are then recreated to induce the iPS cells to mature into red blood cells – of the rare universal blood type O-.
“Although similar research has been conducted elsewhere, this is the first time anybody has manufactured blood to the appropriate quality and safety standards for transfusion into a human being,” said Prof Turner.
There are plans in place for the trial to be concluded by late 2016 or early 2017, he said. It will most likely involve the treatment of three patients with Thalassaemia, a blood disorder requiring regular transfusions. The behaviour of the manufactured blood cells will then be monitored.
“The cells will be safe,” he said, adding that there are processes whereby cells can be removed.
The technique highlights the prospect of a limitless supply of manufactured type O- blood, free of disease and compatible with all patients.
The Latest on: Artificial blood
via Google News
The Latest on: Artificial blood
- Caris Life Sciences Accurately Identifies 21 Cancer Types Using Artificial Intelligence Derived Molecular Signatureson January 19, 2021 at 3:50 am
Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine, today announced positive results from a study using ...
- Novel Artificial Intelligence Tool May Help Patients with Cancer Find, Understand Clinical Trialson January 18, 2021 at 2:24 pm
A group of patients with gastrointestinal cancers reported that a novel artificial intelligence-based search tool made it easier for them to find and understand cancer clinical trials. The tool, ...
- Covid-19 Outbreak: Artificial Pancreas Device System Market Will Generate New Growth Opportunities by 2023on January 17, 2021 at 11:38 am
Artificial Pancreas Device System Market Share, Application and Cost Structure Analysis By Type (Control to Range (CTR) ...
- Scots cops share horrific badger baiting injury pics in bid to stop blood sporton January 16, 2021 at 2:41 am
Scots cops have shared horrific animal injury pictures - in an appeal to the public to try and end badger baiting. Although badgers are normally quiet and submissive, they can be very courageous when ...
- New method uses artificial intelligence to map intestinal bacteria using feceson January 14, 2021 at 9:37 pm
The intestines and their bacteria are sometimes called our ’second brain’, but studying these bacteria in their natural environment is difficult. Now researchers from the University of Copenhagen have ...
- Feces and algorithms: Artificial Intelligence to map our intestinal bacteriaon January 14, 2021 at 9:45 am
Both past and present-day scientists have suspected the intestines of playing a role in various diseases. Present-day studies focus on the intestinal flora's role in physical diseases such as diabetes ...
- Faeces and algorithms: Artificial Intelligence to map our intestinal bacteriaon January 14, 2021 at 8:39 am
The intestines and their bacteria are sometimes called our 'second brain', but studying these bacteria in their natural environment is difficult. Now researchers from the University of Copenhagen have ...
- Artificial hearts: Devices from France's Carmat to go on sale in Europeon January 14, 2021 at 3:49 am
Artificial hearts that could prove a lifeline for those suffering from deadly heart failure are set to go on sale in Europe after the devices from French company Carmat were granted regulatory ...
- WATCH | EU approves sales of the world's first battery-powered artificial hearton January 13, 2021 at 2:03 am
Artificial heartmaker Carmat will begin sales of its devices from the second quarter of 2021 after a long-awaited European Commission approval.
- Artificial Medical Intelligence Announces the Automated Determination of SOFA Scores Extracted from Existing Clinical Documentationon January 7, 2021 at 6:00 am
Allowing Unbiased Analysis of Critical Care Outcomes. MARLBORO, N.J. (PRWEB) Artificial Medical Intelligence (AMI) today announced their ability ...
via Bing News